Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort Study. (29th June 2021)

• Record Type: Journal Article
• Authors: Sagara, Issaka; Woodford, John; Kone, Mamady; Assadou, Mahamadoun Hamady; Katile, Abdoulaye; Attaher, Oumar; Zeguime, Amatigue; Doucoure, M'Bouye; Higbee, Emily; Lane, Jacquelyn; Mohan, Rathy; Doritchamou, Justin; Zaidi, Irfan; Esposito, Dominic; Kwan, Jennifer; Sadtler, Kaitlyn; Dicko, Alassane; Duffy, Patrick E
• Is Part Of: Clinical infectious diseases. Volume 74:Number 6(2022)
• Page Start: 1030
• Page End: 1038
• Publication Date: 2021-06-29
• Subjects: SARS-CoV-2 -- COVID-19 -- Mali -- West Africa -- seroprevalence; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciab589
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Background: The extent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure and transmission in Mali and the surrounding region is not well understood. We aimed to estimate the cumulative incidence of SARS-CoV-2 in 3 communities and understand factors associated with infection. Methods: Between July 2020 and January 2021, we collected blood samples and demographic, social, medical, and self-reported symptoms information from residents aged 6 months and older over 2 study visits. SARS-CoV-2 antibodies were measured using a highly specific 2-antigen enzyme-linked immunosorbent assay optimized for use in Mali. We calculated cumulative adjusted seroprevalence for each community and evaluated factors associated with serostatus at each visit by univariate and multivariate analysis. Results: Overall, 94.8% (2533/2672) of participants completed both study visits. A total of 31.3% (837/2672) were aged <10 years, 27.6% (737/2672) were aged 10–17 years, and 41.1% (1098/2572) were aged ≥18 years. The cumulative SARS-CoV-2 exposure rate was 58.5% (95% confidence interval, 47.5–69.4). This varied between sites and was 73.4% in the urban community of Sotuba, 53.2% in the rural town of Bancoumana, and 37.1% in the rural village of Donéguébougou. Study site and increased age were associated with serostatus at both study visits. There was minimal difference in reported symptoms based on serostatus. Conclusions: The true extent of SARS-CoV-2 exposure in Mali is greater than previously reported and may now approach hypothetical "herd immunity" in urban areas. The epidemiology of the pandemic in the region may be primarily subclinical and within background illness rates. Abstract : This study demonstrates a large, previously unquantified burden of SARS-COV-2 infection in the community in West Africa. In this young study population, there was limited evidence of severe illness and seropositivity rates that may approach hypothetical "herd immunity."